BackNurExone Biologic Overview

NurExone Biologic Other Assets

NurExone Biologic's other assets is $0.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer trimmed avg / median

Loading

NurExone Biologic Other Assets History

Loading

NurExone Biologic vs. peers: Other Assets Comparison

Loading

NurExone Biologic Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NurExone Biologic (NRXBF) FAQ

The latest other assets for NRXBF is $0 as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside NurExone Biologic's historical trend and sector peers before judging valuation or financial health.

Over the past year, NRXBF's other assets moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NurExone Biologic's operating scale or balance-sheet position.

A other assets figure of $0 for NRXBF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NRXBF's other assets ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack NurExone Biologic's other assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.